Effect of atorvastatin on the levels of serum IL-6、ET and MCP-1 in patients with acute cerebral infarction
10.3760/cma.j.issn.1008-6706.2012.11.015
- VernacularTitle:阿托伐他汀对急性脑梗死患者血清白细胞介素-6、内皮素及单核细胞趋化因子-1水平的影响
- Author:
Xinai SUN
;
Xiaofei ZHOU
- Publication Type:Journal Article
- Keywords:
Brain infarction;
Interleukin-6;
Endothelin;
Chemotactic factors;
Atorvastatin
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(11):1630-1631
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect ot atorvastatin on the levels of serum Interleukin-6 ( IL-6),Endothelin(ET) and MCP-1 in patients with acute cerebral infarction(ACI).Methods 100 patients with ACI were randomly divided into the atorvastatin therapy group(n =50) and the conventional therapy group(n =50).At the basic of conventional therapy,the atorvastatin therapy group was treated with Atorvastatin 20mg/d.Both groups were treated for 4 weeks.The levels of serum IL-6,ET and MCP-1 were measured and the scores of neurological deficit ( NDS ) were evaluated before and after treatment.A healthy control group which approximately matched the experimental group included 30 persons.Results The levels of serum IL-6,ET and MCP-1 in both two groups after 14d treatment were significantly lower than those before treatment(t =26.38,49.10,34.51,25.77,32.23,34.68,P ＜0.05),and the levels of serum IL-6,ET and MCP-1 in atorvastatin therapy group was significantly lower than that in conventional therapy group( t =10.10,13.18,23.85,P ＜0.05 ).NDS of both groups after treatment was lower than those before treatment(t =18.38,6.98,P ＜0.05 ),and the score of atorvastatin therapy group was significantly lower than that of conventional therapy group( t =12.00,P ＜ 0.05).Conclusion Atorvastatin could significantly decrease the levels of serum IL-6,ET and MCP-1,and it could promote the neurological fuction recovery in the patients with ACI.
